Skip to main content

Table 5 Correlations between anti-Spike IgG, IgA levels and NAb activity in study groups

From: Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapy

 

Variable

Anti-Spike IgG level

Anti-Spike IgA level

NAb activity

INF

Anti-Spike IgG level

 

.570

.143

Anti-Spike IgA level

.570

 

.547

NAb activity

.143

.547

 

IS-CoronaVac

Anti-Spike IgG level

 

.522

.014*

Anti-Spike IgA level

.522

 

.870

NAb activity

.014*

.070

 

HC-CoronaVac

Anti-Spike IgG level

 

.508

.010*

Anti-Spike IgA level

.508

 

.841

NAb activity

.010*

.841

 

IS-BNT162b2

Anti-Spike IgG level

 

.003**

 < .001**

Anti-Spike IgA level

.003**

 

 < .001**

NAb activity

 < .001**

 < .001**

 

HC-BNT162b2

Anti-Spike IgG level

 

 < .001**

 < .001**

Anti-Spike IgA level

 < .001**

 

 < .001**

NAb activity

 < .001**

 < .001**

 
  1. (IS Immunosuppressive group, HC Healthy controls, INF Infection group, NAb Neutralizing antibody)
  2. **Correlation is significant at the 0.01 level (2-tailed)
  3. *Correlation is significant at the 0.05 level (2-tailed)
  4. (***Spearman correlation test was used for nonparametric variables)
Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us